Clorox/$CLX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Clorox
Since its inception more than 100 years ago, Clorox has expanded into an array of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Nearly 85% of Clorox's sales stem from its US operations.
- Ticker
- $CLX
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 9,200
- Headquarters
- Oakland, United States
- Website
- www.thecloroxcompany.com
Clorox Metrics
BasicAdvanced
$13B
19.24
$5.56
0.58
$3.73
4.68%
Price and volume
Market cap
$13B
Beta
0.58
52-week high
$128.90
52-week low
$79.12
Average daily volume
3.2M
Dividend rate
$3.73
Financial strength
Current ratio
0.654
Quick ratio
0.314
Long term debt to equity
35.777
Total debt to equity
46.231
Dividend payout ratio (TTM)
88.92%
Interest coverage (TTM)
6.47%
Profitability
EBITDA (TTM)
1,297
Gross margin (TTM)
41.94%
Net profit margin (TTM)
9.41%
Operating margin (TTM)
14.29%
Effective tax rate (TTM)
22.33%
Revenue per employee (TTM)
$780,000
Management effectiveness
Return on assets (TTM)
9.62%
Return on equity (TTM)
534.36%
Valuation
Price to earnings (TTM)
19.235
Price to revenue (TTM)
1.805
Price to book
-331.37
Price to tangible book (TTM)
-3.63
Price to free cash flow (TTM)
28.666
Free cash flow yield (TTM)
3.49%
Free cash flow per share (TTM)
3.728
Dividend yield (TTM)
3.49%
Forward dividend yield
4.68%
Growth
Revenue change (TTM)
6.28%
Earnings per share change (TTM)
-12.95%
3-year revenue growth (CAGR)
0.76%
10-year revenue growth (CAGR)
2.16%
3-year earnings per share growth (CAGR)
100.32%
10-year earnings per share growth (CAGR)
1.12%
3-year dividend per share growth (CAGR)
1.52%
10-year dividend per share growth (CAGR)
4.72%
What the Analysts think about Clorox
Analyst ratings (Buy, Hold, Sell) for Clorox stock.
Analyst projections of the future price of Clorox stock.
Bulls say / Bears say
Clorox says first-quarter performance included improving market share, with cleaning growth supported by products such as Scentiva and Clorox Pure. That points to stronger execution and brand momentum, although the year-on-year sales comparison also benefited from lapping last year’s ERP-related shipment shortfall. (The Clorox Company, The Clorox Company)
The GOJO acquisition brings Purell into Clorox’s portfolio and is already contributing to sales; Clorox has also launched a combined professional sales and service platform. If integration succeeds, the added professional and healthcare business could broaden growth beyond its consumer brands. (The Clorox Company)
Clorox ToiletWand grew its top line by about 15% in fiscal 2026 and passed 10% household penetration. That is a concrete example of product improvements and new pack formats expanding demand for an established brand. (The Clorox Company)
Input-cost inflation is squeezing profitability: first-quarter gross margin fell 130 basis points to 40.4%, and management now expects adjusted EPS nearer the low end of its range. The company also expects inflation of about $240 million for the year, raising the risk that pricing and savings will not fully offset costs. (The Clorox Company, Investing.com)
Headline fiscal 2027 organic sales growth of 3.5% to 4.5% includes more than 3.5 points from the ERP comparison, while GOJO adds about 9.5 points to reported sales growth. Excluding that ERP benefit, organic sales are expected to be flat to up only 1%, and second-quarter organic sales are forecast to decline 0% to 2%. (The Clorox Company, Investing.com)
The GOJO deal also brings financing and integration costs: quarterly interest expense rose to $52 million from $23 million a year earlier, and Clorox expects $0.29 per share of acquisition-related costs in fiscal 2027. Those expenses could dilute the earnings benefit from the acquired business. (SEC, The Clorox Company)
Data summarised monthly by Lightyear AI. Last updated on 9 Nov 2026.
Clorox Financial Performance
Revenues and expenses
Clorox Earnings Performance
Company profitability
Upcoming events
Clorox News
AllArticlesVideos
Funds containing Clorox
AllUSDEURGBP
Fund name | Fund size | $CLX weighting |
|---|---|---|
Invesco S&P 500 High Dividend Low Volatility$HDLV | $456M | 2.64% |
Invesco S&P 500 High Dividend Low Volatility£HDLG | $456M | 2.62% |
VanEck Morningstar Wide Moat£MOGB | $371M | 2.48% |
VanEck Morningstar Wide Moat€GMVM | $371M | 2.48% |
VanEck Morningstar Wide Moat$MOAT | $371M | 2.48% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.